Shares of Salesforce Inc. (NYSE:CRM) rose in early trading on Thursday, after the company reported upbeat third-quarter results on Wednesday.

Here are some key analyst takeaways:

Canaccord Genuity analyst David Hynes maintained a Buy rating and price target of $300.

JPMorgan analyst Mark Murphy reiterated an Overweight rating and price target of $365.

Wedbush analyst Dan Ives reaffirmed an Outperform rating and price target of $375.

Goldman Sachs analyst Kash Rangan maintained a Buy rating and price target of $385.

Needham analyst Scott Berg reaffirmed a Buy rating and price target of $400.

Guggenheim Securities analyst John DiFucci reiterated a Neutral rating on the stock.

Check out other analyst stock ratings.

Canaccord Genuity: Salesforce reported "pretty steady" results for the fiscal fourth quarter, with total revenue close to the midpoint of the guidance, Hynes said in a note. Revenue upside was negated by slower growth in MuleSoft and Tableau, he added.

cRPO (current remaining performance obligations) was slightly ahead of expectations, which enabled Salesforce to reiterate its full-year guidance on an organic basis, the analyst stated. The company generated $2.2 billion in free cash flows and returned $4.2 billion to shareholders, "which includes $3.8B in share repurchases and $395M in dividends," he further wrote.

JPMorgan: Salesforce's cRPO grew 11% in constant currency ...